Please Wait...

Key Cardiovascular Mergers and Acquisitions

With over 25 years of experience in Cardiac Safety monitoring services, Bioclinica is a recognized global leader in providing comprehensive services with unrivalled scientific and technical leadership.  Over the last decade, Bioclinica has grown organically and through strategic acquisitions to enhance and strengthen its cardiac safety expertise, resources and offerings for clinical trial sponsors.

In 2004, Bioclinica (formerly Bio-Imaging Technologies) acquired Heartcore BV, a global provider of centralized cardiovascular imaging analysis specializing in various quantitative image analysis services. In 2013, Bioclinica merged with Core Lab Partners, adding renowned scientific expertise from Medifacts to its cardiovascular team, bolstering its centralized cardiovascular services portfolio and expanding its presence in Asia.  Most recently, in 2014, Bioclinica merged with SYNARC, supplementing an already strong cardiac safety program with additional scientific expertise and operations in the area of Echocardiography and cardiovascular imaging.

Bioclinica continues to strengthen its cardiovascular offerings, providing sponsors with world-class expertise, operations and technology to design, manage, and analyze cardiac safety data in support of new treatments.

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

RT @endpts: #FDA revises draft guidance on #raredisease drug R&D https://t.co/KaNVw54MDE by @ZacharyBrennan via @RAPSorg
Bioclinica (8 hours ago)
RT @PrimeVigilance: News and Press Release - Source @EMA_News now available monthly meeting highlights from #Pharmacovigilance #RiskAssessm…
Bioclinica (8 hours ago)
RT @FDA_Drug_Info: New #FDA Draft Guidance for Industry on Rare Diseases – Common Issues in Drug Development: https://t.co/yxaGyMB7hY. http…
Bioclinica (8 hours ago)
Looking to exercise DDDM in clinical trials? Get tips on obtaining, distilling and presenting data in our new white… https://t.co/NkGrS9JnG8
Bioclinica (10 hours ago)
Is your clinical study supply chain management solution increasing the risk of stock out? Ehsan Ramezani gives pers… https://t.co/YCfP3wCvK6
Bioclinica (Yesterday)
Bioclinica's Kate Adamczuk is presenting at #HAI2019 today! Details on this and other scientific findings at HAI… https://t.co/wDQr6ldfcS
Bioclinica (Yesterday)

Latest Blogs:

Nonalcoholic steatohepatitis (NASH) development programs
Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box
Latin America: Benefit from the Right Partner